Paper Details

  1. Home
  2. Paper Details

Comparison of butorphanol nasal spray and fiorinal with codeine in the treatment of migraine.

Author: DavidsonW J, DiamondS, GawelM J, GoldsteinJ, ReichL, SussmanN M, WinnerP

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Butorphanol nasal spray was more effective than Fiorinal with Codeine in treating migraine headaches, but it had more side effects. Butorphanol is a nasal spray that can be used to treat migraines, while Fiorinal with Codeine is an oral medication.
Paper Details　
Original Abstract of the Article :
Butorphanol tartrate is a synthetic mixed agonist-antagonist opioid analgesic. Its transnasal dosage form, which may be self-administered when the use of an opioid analgesic is appropriate, was previously shown to provide rapid relief of migraine pain. In this double-blind, parallel-group, outpatien...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1046/j.1526-4610.1998.3807516.x

データ提供：米国国立医学図書館（NLM）

Butorphanol Nasal Spray: A Quick Fix for Migraines

Migraines can be debilitating, causing intense pain that disrupts daily life. This study investigates the effectiveness of butorphanol nasal spray, a fast-acting medication, for treating migraine pain compared to Fiorinal with Codeine, a standard oral pain reliever. The researchers wanted to determine which treatment provided faster and more effective pain relief.

Butorphanol Nasal Spray: A Promising Option for Migraine Relief

The study showed that butorphanol nasal spray was more effective than Fiorinal with Codeine in reducing migraine pain in the first two hours following treatment. It also demonstrated that butorphanol worked more quickly, providing pain relief within 15 minutes of application. These findings are significant, as they suggest that butorphanol nasal spray could be a valuable tool for migraine sufferers seeking rapid relief.

Easing the Pain of Migraines

This research provides a valuable new option for migraine sufferers seeking fast and effective pain relief. However, it is important to note that butorphanol also had more side effects than Fiorinal with Codeine. Therefore, discussing the benefits and risks with your doctor is crucial before choosing this treatment. This study provides further insight into the diverse range of medication options available to manage migraine pain and helps us better understand how these treatments work.

Dr. Camel's Conclusion

Migraines can be a painful journey through the desert of discomfort, but this research offers a new oasis of relief. Butorphanol nasal spray provides a fast-acting option for managing pain, giving individuals the opportunity to quickly get back on their feet and reclaim their day.

Date :
  1. Date Completed 2006-07-21
  2. Date Revised 2020-12-09
Further Info :

Pubmed ID

15613167

DOI: Digital Object Identifier

10.1046/j.1526-4610.1998.3807516.x

Related Literature

Article Analysis
・Side Effects of butorphanol nasal spray
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.